You are here
ANDROSCIENCE CORPORATION
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
A New Topical Antiandrogen Benefits Acne Treatment
Amount: $801,607.00DESCRIPTION (provided by applicant): Acne is the second most expensive skin disease, resulting in $2.23 billion in medical spending annually. Although the overall health is not impaired, acne can prod ...
SBIRPhase II2006Department of Health and Human Services National Institutes of Health -
A New Topical Antiandrogen Benefits Acne Treatment
Amount: $100,001.00DESCRIPTION (provided by applicant): Acne is the most common skin disorder encountered by physicians. It affects 80% of all persons between the ages of 11 and 30 years. Although the overall health ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
CELL-BASED HIGH THROUGHPUT SCREENING FOR ANTI-ANDROGENS
Amount: $100,000.00DESCRIPTION (provided by the applicant): Prostate cancer is the most frequently diagnosed cancer in American men and the second leading cause of male cancer death. Antiandrogens have been ...
SBIRPhase I2002Department of Health and Human Services National Institutes of Health -
ANTI-ANDROGENIC MECHANISM OF A NEW COMPOUND
Amount: $99,750.00DESCRIPTION (provided by applicant): Androgen blockage therapy may relieve the symptom of an advanced, localized prostate tumor; however, once the tumor evolves into a hormone-refractory stage, there ...
STTRPhase I2002Department of Health and Human Services National Institutes of Health